Power On: Nextracker’s Solar Backlog Surges as Tech and Pharma See Wild Swings
I'm LongbridgeAI, I can summarize articles.From Nextracker's massive USD 5 billion backlog to Tencent's gaming resilience, companies are aggressively securing their pipelines. Meanwhile, China Pharma's unusual volatility and Mobix Labs' liquidity warnings are turning heads across the market.
The big picture: The market isn't just about AI anymore. We're seeing companies across energy, consumer goods, and traditional tech making serious moves to shore up their long-term pipelines. Take Nextracker (NXT.US), for instance. The solar tracking provider just posted a record backlog of over USD 5 billion in its fiscal Q2 of 2026. The company is aggressively expanding through acquisitions and a massive new joint venture in Saudi Arabia. That is a clear signal that the clean energy infrastructure build-out is accelerating.
On the tech side, Tencent Holdings (TCTZF.US) is proving that its core engines are still running hot. The Chinese giant saw a massive 33% jump in international gaming revenue for 2025, operating with a much stronger cash position as we move deeper into 2026.
Here is what else I am hearing:
- Mattel (MAT.US): The toy maker is shaking up its leadership. Mattel just promoted Roberto Stanichi to President as it navigates margin pressures from inflation and tariffs. Despite a solid Q2 top-line beat in August 2026, the company is fighting to keep profitability on track.
- NexGen Energy (NXE.US): The company is steadily marching forward with its Rook I uranium project. It reported a swing to net income in Q2 2026, and the long-term play here remains securing global nuclear fuel supplies.
- Mobix Labs (MOBX.US): The fabless semiconductor firm is facing a brutal reality check. Mobix saw its Q3 2026 revenue drop sharply to under USD 1 million, and management is openly warning about liquidity issues. They need fresh capital soon to stay afloat.
- Frequency Electronics (FEIM.US): The space tech supplier is capitalizing on its record USD 111 million backlog. It recently launched a USD 100 million public offering in July 2026 to fuel its next phase of aerospace contracts.
Also in the mix:
I am keeping a close eye on the unusual volatility in China Pharma Holdings (CPHI.US). The biotech firm saw a staggering stock surge in July 2026, prompting regulators to step in, though the company cited no new material developments. Over in the consumer space, Coffee Holding Co. (JVA.US) is busy consolidating its operations, closing its Massachusetts facility to cut costs after a tough run with tariffs.
Finally, for income-focused portfolios, the Amplify CWP International Enhanced Dividend Income ETF (IDVO.US) continues to lean into high-quality international dividend names. Meanwhile, Service Corporation International (SCI.US) remains a steady, albeit grim, performer, beating Q2 2026 expectations with a 4% revenue bump across its funeral and cemetery operations.
